Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
139.50
-2.50 (-1.76%)
May 14, 2025, 1:30 PM CST

Syngen Biotech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
241.6240.21274.83321.24237.77215.55
Upgrade
Depreciation & Amortization
118.71114.4199.2986.3181.2776.07
Upgrade
Other Amortization
0.270.270.180.190.130.6
Upgrade
Loss (Gain) From Sale of Assets
0.090.150.280.210.630.21
Upgrade
Asset Writedown & Restructuring Costs
----1.81-
Upgrade
Loss (Gain) From Sale of Investments
0.470.49-0.02-0.21-0.980.35
Upgrade
Loss (Gain) on Equity Investments
2.295.32-36.08-26.64-14.81-
Upgrade
Provision & Write-off of Bad Debts
1.166.92-8.5817.820.33-1.77
Upgrade
Other Operating Activities
-2.97-5.3712.2436.6733.37-2.13
Upgrade
Change in Accounts Receivable
-103.24-22.2990.02-101.12-13.1-51.46
Upgrade
Change in Inventory
-7.05-1.191.98-98.11-41.33-51.5
Upgrade
Change in Accounts Payable
-18.325.820.49-62.1257.7812.1
Upgrade
Change in Unearned Revenue
12.514.813.310.184.58-0.66
Upgrade
Change in Other Net Operating Assets
122.68-21.48-52.82103.07-10.9422.84
Upgrade
Operating Cash Flow
368.23348.04415.13277.48336.5220.2
Upgrade
Operating Cash Flow Growth
4.03%-16.16%49.60%-17.54%52.81%-13.73%
Upgrade
Capital Expenditures
-57.74-60.21-91.9-584.27-61.67-272.75
Upgrade
Sale (Purchase) of Intangibles
-4.82-4.13-1.91-0.44--0
Upgrade
Investment in Securities
-20-20---273.84-
Upgrade
Other Investing Activities
-10.07-0.190.12-0.33-0.570.69
Upgrade
Investing Cash Flow
-92.64-84.53-93.68-585.05-336.08-272.06
Upgrade
Short-Term Debt Issued
-25028066050235
Upgrade
Long-Term Debt Issued
--106.4913250-
Upgrade
Total Debt Issued
310250386.49792100235
Upgrade
Short-Term Debt Repaid
--330-430-430-100-185
Upgrade
Long-Term Debt Repaid
--73.63-21.67-14.95-14.02-12.67
Upgrade
Total Debt Repaid
-504.14-403.63-451.67-444.95-114.02-197.67
Upgrade
Net Debt Issued (Repaid)
-194.14-153.63-65.17347.06-14.0237.33
Upgrade
Common Dividends Paid
-135.5-135.5-135.5-108.4-94.85-81.3
Upgrade
Other Financing Activities
-0.050.140.1--0.02
Upgrade
Financing Cash Flow
-329.64-289.09-200.54238.75-108.88-43.99
Upgrade
Foreign Exchange Rate Adjustments
0.680.62-0.080.06-0.16-0.12
Upgrade
Net Cash Flow
-53.37-24.96120.84-68.75-108.62-95.98
Upgrade
Free Cash Flow
310.49287.83323.23-306.79274.83-52.55
Upgrade
Free Cash Flow Growth
18.23%-10.95%----
Upgrade
Free Cash Flow Margin
15.28%14.29%17.59%-15.89%18.68%-4.01%
Upgrade
Free Cash Flow Per Share
11.4610.6111.91-11.3110.13-1.94
Upgrade
Cash Interest Paid
9.359.358.844.893.22.46
Upgrade
Cash Income Tax Paid
86.6886.6875.360.1528.8755.18
Upgrade
Levered Free Cash Flow
302.52200.8248.25-368.73240.8-108.78
Upgrade
Unlevered Free Cash Flow
307.8206.6253.78-365.56242.8-107.24
Upgrade
Change in Net Working Capital
-63.6233.31-58.8293.83-47.1573.19
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.